FindTrial
Sign In

Observation of giving blood products to sick children

Transfusion Practices in Critically Ill Children with Malignancy and their outcomes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066995
Enrollment
200
Registered
2024-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R70-R79- Abnormal findings on examination of blood, without diagnosis Health Condition 2: C00-D49- Neoplasms

Interventions

Intervention1: Nil: NA Control Intervention1: Nil: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria:- 1. Age below 18yrs 2. Critically ill children admitted in ICU (for one year from the IEC approval and CTRI registration) 3. Patient who will receive at least one transfusion (PCV, FFP, Platelets, Cryoprecipitate, granulocytes etc)

Exclusion criteria

Exclusion criteria: Exclusion Criteria:- 1. Refuses for consent or not able to obtain consent from participants LAR

Design outcomes

Primary

MeasureTime frame
To assess all-cause mortalityTimepoint: Until ICU discharge or death—

Secondary

MeasureTime frame
Transfusion indication, triggers and efficacyTimepoint: Until ICU discharge or death—

Countries

India

Contacts

Public ContactDr Shilpushp Bhosale

Tata Memorial Centre

shilbhosale@gmail.com9619310657

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026